Inhibition of NF-κB pathway by various agents, such as pyrrolidine dithiocarbamate24, 25 and celastrol26, could lead to amelioration of renal injury, suggesting the importance of NF-κB as a therapeutic target of renal diseases. This evidence concerns the gene NFKB1 and kidney disorder.